TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biofokus
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,961
|
1,816
|
1,974 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
172
|
91
|
188 |
| Total assets |
2,524
|
2,363
|
2,548 |
| Current assets |
2,506
|
2,344
|
2,545 |
| Current liabilities |
737
|
593
|
759 |
| Equity capital |
1,787
|
1,770
|
1,789 |
| - share capital |
4
|
5
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
70.8%
|
74.9%
|
70.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
8.8%
|
5.0%
|
9.5% |
| Return on assets (ROA) |
6.8%
|
3.9%
|
7.4% |
| Current ratio |
340.0%
|
395.3%
|
335.3% |
| Return on equity (ROE) |
9.6%
|
5.1%
|
10.5% |
| Change turnover |
260
|
-55
|
-80 |
| Change turnover % |
15%
|
-3%
|
-4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.